[Cardiogenic shock: treatment of the near future].
The mortality rate for cardiogenic shock has decreased over the past decade. These improvements are presumed to reflect increased use of intraaortic ballon counterpulsation and coronary reperfusion strategies which, by restoring patency to the infarct-related artery, can limit infarct size. Despite these therapeutic measures, mortality rates remain elevated. Current strategies are aimed at decreasing reperfusion times and measures to preserve and prolong myocardial cell viability.